Placement of a Long Intestinal Tube in Patients with Early Postoperative Small Bowel Obstruction under Fluoroscopic Guidance

Objective To investigate the placement of a long tube into the small intestine under fluoroscopic guidance and to evaluate its decompression effect on early postoperative small bowel obstruction(EPSBO).Methods Fifty-four patients with EPSBO requiring decompression between April 2010 and July 2014 were enrolled in the study.Insertion of a long tube was guided by fluoroscopy.We first used the guide wire to pass the pylorus and then used the 10 Fr feeding tube as an exchangeable tube to put the superstiff wire into the duodenum.Finally the long tube could be passed over the guide wire through the pylorus into the intestine.The total procedure time,the radiation exposure time,and the incidence of complications were evaluated.Results The long tubes passed into the jejunum on initial insertion for all patients,so the success rate of this technique was 100%.The long tube was inserted into ileum in 18 patients.The mean total procedure time was 34.4±8.6 minutes,and the mean radiation exposure time 18.9±6.8 minutes.A total of 47 patients(87%) experienced full recovery following long-tube decompression and without the need for surgical intervention.Conclusions Using the wire-exchange technique,it is easy to place a long tube into the small bowel under fluoroscopic guidance.This decompression method is safe and effective for management of EPSBO.

Adhesive small bowel adhesions obstruction: Evolutions in diagnosis, management and prevention

Intra-abdominal adhesions following abdominal surgery represent a major unsolved problem. They are the first cause of small bowel obstruction. Diagnosis is based on clinical evaluation, water-soluble contrast followthrough and computed tomography scan. For patients presenting no signs of strangulation, peritonitis or severe intestinal impairment there is good evidence to support non-operative management. Open surgery is the preferred method for the surgical treatment of adhesive small bowel obstruction, in case of suspected strangulation or after failed conservative management, but laparoscopy is gaining widespread acceptance especially in selected group of patients. "Good" surgical technique and anti-adhesive barriers are the main current concepts of adhesion prevention. We discuss current knowledge in modern diagnosis and evolving strategies for management and prevention that are leading to stratified care for patients.

A prospective randomized trial of transnasal ileus tube vs nasogastric tube for adhesive small bowel obstruction

AIM:To study the therapeutic efficacy of a new transnasal ileus tube advanced endoscopically for adhesive small bowel obstruction.METHODS:A total of 186 patients with adhesive small bowel obstruction treated from September 2007 to February 2011 were enrolled into this prospective randomized controlled study.The endoscopically advanced new ileus tube was used for gastrointestinal decompression in 96 patients and ordinary nasogastric tube(NGT) was used in 90 patients.The therapeutic efficacy was compared between the two groups.RESULTS:Compared with the NGT group,the ileus tube group experienced significantly shorter time for relief of clinical symptoms and improvement in the findings of abdominal radiograph(4.1 ± 2.3 d vs 8.5 ± 5.0 d) and laboratory tests(P < 0.01).The overall effectiveness rate was up to 89.6% in the ileus tube group and 46.7% in the NGT group(P < 0.01).And 10.4% of the patients in the ileus tube group and 53.3% of the NGT group underwent surgery.For recurrent adhesive bowel obstruction,ileus tube was also significantly more effective than NGT(95.8% vs 31.6%).In the ileus tube group,the drainage output on the first day and the length of hospital stay were significantly different depending on the treatment success or failure(P < 0.05).The abdominal radiographic improvement was correlated with whether or not the patient underwent surgery.CONCLUSION:Ileus tube can be used for adhesive small bowel obstruction.Endoscopic placement of the ileus tube is convenient and worthy to be promoted despite the potential risks.

Decompression of the small bowel by endoscopic long-tube placement

AIM:To investigate and compare the decompression effect on small bowel obstruction of a long tube inserted using either endoscopic or fluoroscopic placement.METHODS:Seventy-eight patients with small bowel obstruction requiring decompression were enrolled in the study and divided into two groups.Intubation of a long tube was guided by fluoroscopy in one group and by endoscopy in the other.The duration of the procedure and the success rate for each group were evaluated.RESULTS:A statistically significant difference in the mean duration of the procedure was found between the fluoroscopic group(32.6±14.6 min)and the endoscopic group(16.5±7.8 min)among the cases classified as successful(P<0.05).The success rate was significantly different between the groups:88.6%in the fluoroscopic group and 100%in the endoscopic group(P <0.05).CONCLUSION:For patients with adhesive small bowel obstruction,long-tube decompression is recommended and long-tube insertion by endoscopy was superior to fluoroscopic placement.

Challenges in diagnosing adhesive small bowel obstruction

Adhesive small bowel obstruction(ASBO)is the most frequently encountered surgical disorder of the small intestine.Up to 80%of ASBO cases resolve spontaneously and do not require invasive treatment.It is important to identify such patients that will benefit from conservative treatment in order to prevent unnecessarily exposing them to the risks associated with surgical intervention,such as morbidity and further adhesion formation.For the remaining ASBO patients,timely surgical intervention is necessary to prevent small bowel strangulation,which may cause intestinal ischemia and bowel necrosis.While early identification of these patients is key to decreasing ASBO-related morbidity and mortality,the non-specific signs and laboratory findings upon clinic presentation limit timely diagnosis and implementation of appropriate clinical management.Combining the clinical presentation findings with those from other diagnostic imaging modalities,such as abdominal X-ray,computed tomography-scan and water-soluble contrast studies,will improve diagnosis of ASBO and help clinicians to better evaluate the potential of conservative management as a safe strategy for a particular patient.Nonetheless,patients who present with moderate findings by all these approaches continue to represent a challenge.A new diagnostic strategy is urgently needed to further improve our ability to identify early signs of strangulated bowel,and this diagnostic modality should be able to indicate when surgical management is required.A number of potential serum markers have been proposed for this purpose,including intestinal fatty acid binding protein andα-glutathione S transferase.On-going research is attempting to clearly define their diagnostic utility and to optimize their potential role in determining which patients should be managed surgically.

Acute small bowel obstruction caused by endometriosis:A case report and review of the literature

Gastrointestinal involvement of endometriosis has been found in 3%-37% of menstruating women and exclusive localization on the ileum is very rare(1%-7%).Endometriosis of the distal ileum is an infrequent cause of intestinal obstruction,ranging from 7% to 23% of all cases with intestinal involvement.We report a case in which endometrial infiltration of the small bowel caused acute obstruction requiring emergency surgery,in a woman whose symptoms were not related to menses.Histology of the resected specimen showed that endometriosis was mainly prevalent in the muscularis propria and submucosa and that the mucosa was not ulcerated but had inflammation and glandular alteration.Endometrial lymph node involvement,with a cystic glandular pattern was also detected.

Risk Factors for the Development of Adhesive Small Bowel Obstruction after Abdominal and Pelvic Operations

Introduction: Adhesive small bowel obstruction (SBO) is a disease process that has been difficult to prevent. Mechanical barriers and chemical agents exist to disrupt the formation of adhesions following surgery but each associated with medical risk and financial burden. Identifying risk factors for developing SBO in patients post laparotomy would aid in the appropriate use of such agents. We hypothesize that there might be additional risk factors that are associated with a higher likelihood of SBO. Methods: A retrospective analysis from 2008 to 2012 was performed. Cases of SBO following previous laparotomy were compared to those without SBO. Results: 468 medical records were reviewed (57% male). Operations that caused the highest risks for SBO included gynecological, colorectal and hernia operations with prosthetic materials. 66% percent of patients underwent a prior abdominal or pelvic high-risk procedure. The average time from surgery to the development of SBO was 24 months (median 19 months). Patients who developed SBO had a median age of 58.4 years on initial surgery, average previous operative time of 4.3 hours, and an av-erage of two prior operations. For every hour of operative time, the odds of developing SBO increased by 33% (p 3 decreased the odds of SBO (p = 0.05). Conclusions: Longer operative times are associated with post-operative adhesive small bowel obstruction. Patients with an ASA score greater than or equal to 3 appear to have a reduced risk of adhesive small bowel obstruction.

Successful management of adhesion related small bowel ischemia without intestinal resection: A case report and review of literature

BACKGROUND Intraabdominal adhesions develop spontaneously or after an inflammatory process or surgical procedure in the abdomen.They are the most common cause of small bowel obstruction(SBO).SBO occasionally leads to intestinal ischemia(In Is)which can be a life-threatening condition that requires management as soon as possible.We herein report a case of SBO with In Is presented in our institution and treated without intestinal resection.CASE SUMMARY A 34-year-old man presented at the emergency department after a 12-h-onset diffuse abdominal pain,bloating and nausea.He had a history of traumatic right hepatectomy 11 years ago as well as adhesiolysis and resection of a long part of small bowel 2 years ago.An abdominal computed tomography(CT)showed dilated loops that led to the diagnosis of SBO.Due to deteriorating lactic acidosis,the patient was operated.Torsion of the small bowel around an adhesion led to2.30 m of ischemic ileum.After the application of N/S 40°C for 20 min,the intestine showed signs of improvement and it was decided to avoid resection and instead temporary close the abdomen with vacuum-pack technique.At the second-look laparotomy 48 h later,the intestine appeared normal.The patient was discharged on the 8 th post-op day in excellent condition.CONCLUSION In case of SBO caused by adhesions,extreme caution is needed if In Is is present,as the clinical signs are mild and you should rely for diagnosis in CT findings and lactate levels.Conservative surgical approach could reverse the effects of In Is,if performed quickly,so that intestinal resection is avoided and should be used even when minimum signs of viability are present.

Giant Meckel's diverticulum: An exceptional cause of intestinal obstruction

Meckel's diverticulum(MD) results from incomplete involution of the proximal portion of the vitelline(also known as the omphalomesenteric) duct during weeks 5-7 of foetal development. Although MD is the most commonly diagnosed congenital gastrointestinal anom-aly, it is estimated to affect only 2% of the population worldwide. Most cases are asymptomatic, and diagno-sis is often made following investigation of unexplained gastrointestinal bleeding, perforation, inflammation or obstruction that prompt clinic presentation. While MD range in size from 1-10 cm, cases of giant MD(≥ 5 cm) are relatively rare and associated with more severe forms of the complications, especially for obstruction. Herein, we report a case of giant MD with secondary small bowel obstruction in an adult male that was suc-cessfully managed by surgical resection and anasto-mosis created with endoscopic stapler device(80 mm, endo-GIA stapler). Patient was discharged on post-operative day 6 without any complications. Histopatho-logic examination indicated Meckel's diverticulitis with-out gastric or pancreatic metaplasia.

Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment

Inflammatory bowel diseases(IBD),Crohns disease and ulcerative colitis,are chronic conditions associated with high morbidity and healthcare costs.The natural history of IBD is variable and marked by alternating periods of flare and remission.Even though the use of newer therapeutic targets has been associated with higher rates of mucosal healing,a great proportion of IBD patients remain symptomatic despite effective control of inflammation.These symptoms may include but not limited to abdominal pain,dyspepsia,diarrhea,urgency,fecal incontinence,constipation or bloating.In this setting,commonly there is an overlap with gastrointestinal(GI)motility and absorptive disorders.Early recognition of these conditions greatly improves patient care and may decrease the risk of mistreatment.Therefore,in this review we describe the prevalence,diagnosis and treatment of GI motility and absorptive disorders that commonly affect patients with IBD.

补中益气汤联合穴位贴敷治疗术后早期炎性肠梗阻临床研究

目的 探讨补中益气汤联合穴位贴敷治疗术后早期炎性肠梗阻(EPISBO)的临床效果。方法 纳入石家庄市中医院2019年6月至2022年3月收治的EPISBO病人110例,按随机数字表法分为对照组和治疗组(n=55),所有病人给予胃肠减压、静脉液体复苏、纠正水电解质及酸碱平衡紊乱、抗感染等基础对症治疗,对照组病人在基础对症治疗的基础上给予穴位贴敷治疗,治疗组病人在对照组的基础上加服补中益气汤,治疗周期为7 d。观察两组血清白细胞介素-1β(IL-1β)、内毒素、血管活性肽(VIP)、一氧化氮(NO)、去甲肾上腺素(NE)、5-羟色胺(5-HT)水平、胃肠功能改善时间、临床疗效以及不良反应发生率。结果 治疗组总有效率(92.73%)显著高于对照组(78.18%)(P<0.05);治疗1 d、7 d后,两组血清IL-1β、内毒素水平均显著降低,且治疗组低于对照组(P<0.05);治疗1 d、7 d后,两组血清VIP、NO、NE、5-HT水平均显著降低,且治疗7 d后治疗组血清VIP、NO、NE水平显著低于对照组(P<0.05);治疗组肠鸣音恢复时间、肛门排气恢复时间、进食恢复时间、住院时间均显著低于对照组(P<0.05)。结论 补中益气汤联合穴位贴敷对EPISBO病人的临床疗效显著,可有效降低血清IL-1β、内毒素水平,改善胃肠功能。

短肠综合征患儿小肠移植术后早期移植肠康复的护理

总结5例各种原因所致短肠综合征患儿小肠移植术后早期移植肠康复的护理。针对儿童小肠移植手术复杂、术后并发症多、营养不良、心理应激、移植肠造口居家管理等问题,采取建立促进移植肠康复多学科协作团队;做好移植肠早期并发症的预防与护理;实施移植肠分阶段营养支持与护理;稳定患儿情绪配合移植肠康复的治疗与护理;开展患儿家长移植肠造口居家管理技能培训及考核等护理措施。经过积极治疗和护理,5例患儿术后早期移植肠功能顺利康复,出院后按时复诊;术后3~4个月均如期完成“回肠造口还纳术”,随访4~12个月,恢复良好。

六磨汤联合芒硝外敷对术后早期炎性肠梗阻患者肠道屏障功能及血清血管活性肠肽水平的影响

目的:探讨六磨汤联合芒硝外敷对术后早期炎性肠梗阻(EPISBO)患者肠道屏障功能及血清血管活性肠肽(VIP)水平的影响。方法:选取2021年11月—2022年11月我院收治的符合标准的98例EPISBO患者,采用随机数字表法分为对照组(n=49)及研究组(n=49)。对照组进行常规治疗,研究组在对照组的基础上给予六磨汤联合芒硝外敷治疗。比较两组临床疗效、治疗前后胃肠功能恢复时间、胃肠激素水平、血清炎症因子水平和不良反应发生率。结果:研究组总有效率高于对照组(91.84%vs 75.51%,P<0.05)。研究组腹部症状缓解时间、肠鸣音恢复时间以及肛门排气时间均低于对照组(6.37±0.97 vs 8.56±1.29,5.31±0.76 vs 7.16±0.93,6.37±1.09 vs 8.16±1.16,P<0.05)。治疗前,两组的血清VIP、胃动素(MOT)、胃泌素(GAS)水平无统计学差异(31.76±5.87 vs 31.08±5.63,187.29±26.39 vs 186.32±25.97,108.67±21.76 vs 111.62±26.89,P>0.05),治疗后,两组的血清VIP水平都有所降低,MOT、GAS水平都有所升高,相对而言,研究组的血清VIP水平降低更多,MOT、GAS水平升高更多(16.23±3.66 vs 20.75±4.37,289.67±38.52 vs 231.56±31.26,179.65±39.55 vs 142.34±31.76,P<0.05)。治疗前,两组的血清肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、白细胞介素-6(IL-6)水平无差异(65.19±7.83 vs 63.13±7.56,67.59±9.27 vs 67.11±8.96,59.13±8.52 vs 58.77±8.78,P>0.05),治疗后,两组的血清TNF-α、CRP、IL-6水平都有所降低,且研究组的血清TNF-α、CRP、IL-6水平降低更多(19.37±3.65 vs 29.82±5.23,17.26±3.25 vs 27.51±4.16,15.56±2.44 vs 23.41±3.53,P<0.05)。结论:六磨汤联合芒硝外敷可有效改善EPISBO患者的临床症状,降低胃肠功能恢复的时间,调节胃肠激素水平和血清炎症因子,且具有一定的安全性。

超声内镜引导下肠-肠吻合术治疗恶性肠梗阻的应用效果

目的 探讨超声内镜引导下肠-肠吻合术(EUS-EE)治疗恶性肠梗阻(MBO)的效果。方法回顾性分析2022年6月-2023年12月该院收治的14例因MBO行EUS-EE患者的临床资料。术前采用改良式肠道准备方案行肠道准备,统计分析EUS-EE术后患者症状缓解情况、营养状态改善情况和并发症发生情况。结果 14例均成功实施EUS-EE,选用结直肠梗阻评分系统(CrOSS),评估术前和术后肠梗阻症状和缓解情况,术后1周,CrOSS评分由术前的1至2分上升至2~4分;术后1周,患者主观总体评估(PGSGA)量表评分为(9.64±3.13)分,明显低于术前的(12.36±3.22)分,差异有统计学意义(t=2.26,P=0.032);术后5例出现体温升高,3例出现气腹,2例出现短肠综合征,经过对症治疗,均得到缓解。术后随访1年内,患者的中位生存时间为81 (41,500) d,1年生存率为64.29%。结论 EUS-EE具有症状缓解率高、创伤小和再干预率低等优点。对于基础状况不佳或预期生存时间短的患者,EUS-EE有助于改善身体不适症状,提高患者生活质量,延长生存周期。

血小板/淋巴细胞比率预测肠梗阻导管治疗小肠梗阻病人非手术治疗失败的研究

目的:探究血小板/淋巴细胞比值(PLR)对肠梗阻导管治疗的小肠梗阻病人非手术治疗失败的预测价值。方法:回顾性收集中国人民解放军联勤保障部队第九〇〇医院收治的肠梗阻导管治疗的小肠梗阻病人临床资料。Logistic回归分析确定中转手术的独立预测因素。限制性立方样条(RCS)评估PLR和中转手术之间的剂量-反应关系。受试者工作特征(ROC)曲线评价预测模型的效能。结果:共纳入73名肠梗阻导管保守治疗的小肠梗阻病人,25(34.2%)名病人保守治疗后效果不佳中转为手术干预。多因素Logistic回归分析结果显示,PLR是中转手术的独立预测因子(P=0.032)。RCS分析显示,随着PLR的增高,中转手术的风险逐渐增大,两者之间呈非线性相关。ROC曲线显示,将PLR纳入预测模型后可以显著增强其预测效能(均P<0.05)。结论:PLR与肠梗阻导管治疗的小肠梗阻病人中转手术密切相关,两者之间呈非线性关系。将PLR纳入预测模型后可以显著增强其预测效能,从而为临床医生的决策提供参考价值。

1例小肠切除术后炎性肠梗阻合并肠系膜上动脉综合征病案分析

术后早期炎性小肠梗阻是腹部手术后的并发症之一,大多数梗阻在营养支持后会自行缓解。但肠道功能恢复需要较长时间,治疗费用高且易发生相关并发症。术后早期炎性小肠梗阻也是继发粘连性肠梗阻的危险因素之一,少数患者保守治疗无效,不得不接受高风险的手术治疗。术后早期炎性小肠梗阻继发肠系膜上动脉综合征的病例相对少见,通过针灸、激素、水溶性造影剂等综合治疗,争取及早放置肠内营养管,是该类患者治疗的关键。

Prospective evaluation of intestinal decompression in treatment of acute bowel obstruction from Crohn’s disease

Background:Conservative therapy for Crohn’s disease(CD)-related acute bowel obstruction is essential to avoid emergent surgery.The present study aimed to evaluate the efficacy of using a long intestinal decompression tube(LT)in treatment of CD with acute intestinal obstruction.Methods:This is a prospective observational study.Comparative analysis was performed in CD patients treated with LT(the LT group)and nasogastric tube(the GT group).The primary outcome was the avoidance of emergent surgery.Additionally,predictive factors for failure of decompression and subsequent surgery were investigated.Results:There were 27 and 42 CD patients treated with LT and GT,respectively,in emergent situations.Twelve(44.4%)patients using LT were managed conservatively without laparotomy,while only nine(21.4%)patients in the GT group were spared from emergent surgery(P<0.05).Both in surgery-free and in surgery patients,the time to alleviation of symptoms was significantly shorter in the LT groups than in the GT groups(both P<0.01).C-reactive protein decrease after intubation and 48-hour drainage volume>500mL were predictors of unavoidable surgery(both P<0.05).The rate of temporary stoma and incidence of incision infection in the LT surgery group were significantly lower than those in the GT group(both P<0.05).No significant differences were observed in the frequency of medical and surgical recurrences between the LT and GT groups(all P>0.05).Conclusions:Endoscopic placement of LT could improve the emergent status in CD patients with acute bowel obstruction.The drainage output and changes in C-reactive protein after intubation could serve as practical predictive indices for subsequent surgery.Compared to traditional GT decompression,LT decompression was associated with fewer short-term complications and did not appear to affect long-term recurrence.

肠梗阻术中无损伤肠减压装置的设计与应用效果

目的设计制作无损伤肠减压装置并探讨其在肠梗阻患者术中行密闭式肠减压的效果。方法选取2020年1月至2021年9月在我院行肠减压术的78例肠梗阻患者作为研究对象,采用掷硬币法将其分为对照组(n=40例)和实验组(n=38例)。对照组采用传统肠减压方法,实验组采用自行设计的无损伤肠减压装置法(装置包括螺纹管、收纳袋、锥筒、平椎调节器、尾管、第一通孔、第二通孔共7部分)。比较两组患者肠内容物污染术野例数、肠内容减压引流量、肠减压操作时间、手术时间、住院时间、并发症发生率等指标。结果两组患者一般资料比较差异无统计学意义(P>0.05);实验组肠内容物污染术野例数为10例(26.32%),对照组40例(100%);两组肠内容减压引流量差异有统计学意义[750.00(728.75,827.50)mL vs.535.00(520.00,557.50)mL,P<0.05];实验组肠减压操作时间、手术时间及住院时间均少于对照组,差异均有统计学意义(P<0.05);实验组无切口感染,对照组6例,组间差异有统计学意义(P<0.05),两组的其他腹腔感染及吻合口瘘、肠造瘘口相关并发症等差异均无统计学意义(P>0.05)。结论无损伤肠减压装置能够在肠梗阻手术中进行密闭式肠减压,减少术野污染,缩短手术和住院时间,降低切口感染发生率。

血清ITF3、HMGB1水平对结直肠癌患者根治术后早期炎性肠梗阻的诊断价值

目的探讨血清肠三叶因子3(ITF3)和高迁移率族蛋白B1(HMGB1)水平对结直肠癌患者根治术后早期炎性肠梗阻(EPISBO)的诊断价值。方法选取2020年2月至2023年2月在我院确诊结直肠癌并进行手术的277例患者作为研究对象,选取同期在我院体检健康者277例为对照组。检测并分析两组患者血清ITF3、HMGB1水平。采用Logistic回归分析影响结直肠癌患者发生EPISBO的因素。采用Pearson分析EPISBO患者血清ITF3、HMGB1的相关性。受试者工作特征(ROC)曲线分析ITF3、HMGB1水平对结直肠癌患者EPISBO的诊断效能。结果研究组患者血清ITF3水平显著低于对照组(P<0.05),HMGB1水平显著高于对照组(P<0.05);Pearson等级相关分析显示,EPISBO患者血清ITF3、HMGB1水平呈现负相关性(r=-0.671,P<0.001)。Logistic回归结果显示,ITF3是结直肠癌患者术后发生EPISBO的独立保护因素(P<0.05),HMGB1是导致EPISBO的独立危险因素(P<0.05)。ROC曲线显示,血清ITF3、HMGB1联合应用诊断EPISBO的临床价值优于ITF3、HMGB1单独检测(Z_(二者联合-ITF3)=3.112、P=0.002,Z_(二者联合-HMGB1)=2.000、P=0.046)。结论结直肠癌术后发生EPISBO患者血清ITF3水平显著降低,HMGB1表达水平显著升高,二者对EPISBO的临床诊断预测具有重要意义。

胃肠减压联合生长抑素治疗对恶性肠梗阻患者免疫炎症及肠黏膜屏障的影响

目的:探讨胃肠减压联合生长抑素治疗对恶性肠梗阻患者免疫炎症及肠黏膜屏障的影响。方法:选取64例恶性肠梗阻患者作为研究对象,按照治疗方法的不同将患者分为对照组(n=30)和观察组(n=34)。对照组给予对症治疗和生长抑素治疗;观察组在对照组治疗基础上给予胃肠减压治疗。比较两组患者临床疗效、临床症状改善情况、炎症因子、T淋巴细胞亚群水平、肠黏膜屏障功能及不良反应发生情况。结果:观察组治疗总有效率为94.12%,高于对照组的73.33%(P<0.05),呕吐停止时间、腹痛腹胀消失时间、肛门恢复排气时间、影像学积气、积液消失时间均短于对照组(P<0.05)。与治疗前比较,两组患者治疗后白细胞介素1β(IL-1β)、IL-6、IL-8、IL-10、肿瘤坏死因子α(TNF-α)、CD8^(+)、D乳酸、内毒素(ET)及二胺氧化酶(DAO)水平均下降(P<0.05),且观察组低于对照组(P<0.05);CD4^(+)、CD4^(+)/CD8^(+)水平均升高(P<0.05),且观察组高于对照组(P<0.05)。两组患者治疗期间均无不良反应发生。结论:恶性肠梗阻患者采用胃肠减压联合生长抑素治疗的临床疗效更佳,且在控制机体炎症反应、缓解临床症状、促进免疫功能及肠黏膜屏障功能恢复方面的效果更好,安全性较高。